Variceal bleeding and portal hypertensive gastropathy

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 1, 2001, Pages 81-88

  Dagher, L ^a   Burroughs, A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Gastrointestinal haemorrhage; Human; Hypertension; Oesophageal and gastric varices; Portal

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE 5 NITRATE;

BLEEDING; COST BENEFIT ANALYSIS; DISEASE MARKER; DRUG EFFICACY; DRUG SAFETY; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCLEROTHERAPY; STOMACH DISEASE; SURVIVAL; TREATMENT INDICATION; VARICOSIS;

ADRENERGIC BETA-ANTAGONISTS; ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIGATION; LIVER CIRRHOSIS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; SCLEROTHERAPY; VARICOSE VEINS;

EID: 0035145774     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200101000-00017     Document Type: Review

References (56)

1. The cellular pathogenesis of portal hypertension: Stellate cell contractility, endothelin and nitric oxide
2. The hepatic circulation in health and disease: Report of a single-topic symposium
3. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
4. Beneficial hemodynamic effects of bosentan, a mixed ETa and ETb receptor antagonist, in portal hypertensive rats
5. Endothelial dysfunction in the intrahepatic microcirculation of the cirrhotic rat
6. Portal pressure, presence of gastroesophageal varices and variceal breeding
7. Prediction of the 1st variceal hemorrhage in patients with cirrhosis of the liver and esophageal-varices a prospective multicenter study
8. Portal hypertension and variceal bleeding: An AASLD single topic symposium
9. Hepatic venous pressure measurement: An old test as new prognostic marker in cirrhosis?
10. Variceal pressure is a factor predicting the risk of a first variceal bleeding: A prospective cohort study in cirrhotic patients
11. Clinical events after transjugular intrahepatic portosystemic shunt: Correlation with hemodynamic findings
12. Prognostic value of early measurements of portal pressure in acute variceal bleeding
13. A predictive model for failure to control bleeding during acute variceal haemorrhage
14. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding
15. Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: A 10-year prospective study
16. Sequential variceal pressure measurements by endoscopic needle puncture during maintenance sclerotherapy: The correlation between variceal pressure and variceal rebleeding
17. Should measurement of hemodynamics in portal hyperiension be dynamic?
18. Postprandial changes in portar haemodynamics in patients with cirrhosis
19. The postprandial portal flow is related to the severity of portal hypertension in liver cirrhosis
20. Hemodynamic effects of the somatostatin analag lantreotide in humans: Placebo-controlled, cross-over dose-ranging echo doppler study
21. Bacterial infection in the pathogenesis of variceal bleeding
22. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage
23. Prognostic significance of bacterial infections in bleeding cirrhotic patients: A prospective study
24. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage
25. Prevention of first bleeding in cirrhosis: A meta-analysis of randomized trials of nonsurgical treatment
26. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices an analysis of data and prognostic factors in 589 patients from four randomized clinical trials
27. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
28. Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long term survival in cirrhosis
29. Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease - A randomized, single-blind multicenter clinical trial
30. Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: Preliminary report of a randomized controlled trial
31. Primary prevention of bleeding from esophagear varices
32. Somatostatin or octreotide for acute bleeding oesophageal varices (Cochrane review)
33. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients
34. A discussion of how terlipressin limits mortality in cases of bleeding oesophageal varices
35. Therapeutic benefit of vasoactive drugs for acute variceal bleeding: A real pharmacological effect, or a side-effect of definitions in trials?
36. Sclerotherapy for actively bleeding esophageal varices in male alcoholics with cirrhosis
37. Portal hyperiensive bleeding: Prevention and treatment
38. Prevalence, classification and natural history of gastric varices a long term followup-study in 568 portal-hypertension patients
39. N-butyl-2-cyanoacrylate: A supplement to endoscopic sclerotherapy
40. Ethanolamine oleate versus butyl cyanoacrylater for bleeding gastric varices a non randomized study
41. Thrombin - An effective treatment for gastric variceal hemorrhage
42. Gastric varices
43. Gastric variceal ligation: A new technique
44. "Salvage" transjugular intrahepatic portosystemic shunts: Gastric fundal compared with esophageal variceal bleeding
45. Gastric antral vascular ectasia in cirrhotic patients: Absence of relation with portal hypertension
46. Relationship of portal pressure and colorectal vasculopathy in patients with cirrhosis
47. Proceedings of the Second International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies
48. A comparison of sclerotherapy with staple transection of the oesophagus for the emergency control of bleeding from oesophageal varices
49. Limitations of multiple injection sclerotherapy sessions for acute variceal bleeding
50. Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy
51. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
52. Distal splenorenal shunt
53. Partial versus total portacaval-shunt in alcoholic cirrhosis results of a prospective, randomized clinical trial
54. A prospective trial of TIPS vs small diameter prosthetic H-graft portacaval shunt in the treatment of bleeding varices
55. AISF practical guidlines for portal hypertension
56. Developing consensus in portal hypertension